Cargando…
Nonselective beta-blockers may lead to stage 2 acute kidney injury and waitlist mortality in child class C cirrhosis
BACKGROUND AND AIMS: Nonselective beta-blockers (NSBB) protect patients with compensated cirrhosis; however, it is unclear if NSBB is associated with acute kidney injury (AKI) in patients with decompensated cirrhosis. We aimed to determine if the use of NSBB was associated with an increased risk of...
Autores principales: | Lai, Mason, Fenton, Cynthia, Ge, Jin, Rubin, Jessica, Lai, Jennifer C., Cullaro, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531476/ https://www.ncbi.nlm.nih.gov/pubmed/37756037 http://dx.doi.org/10.1097/HC9.0000000000000255 |
Ejemplares similares
-
Nonselective beta-blocker use is associated with increased hepatic encephalopathy-related readmissions in cirrhosis
por: Fallahzadeh, Mohammad Amin, et al.
Publicado: (2022) -
Hemodynamic Evaluation of Nonselective β-Blockers in Patients with Cirrhosis and Refractory Ascites
por: Ferrarese, Alberto, et al.
Publicado: (2018) -
Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD
por: Huang, Yueh Lan, et al.
Publicado: (2017) -
Association Between Nonselective Beta-Blocker Use and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Without Cirrhosis and Decompensation
por: Cheng, He-Yun, et al.
Publicado: (2022) -
Is there any vindication for low dose nonselective β-blocker medication in patients with liver cirrhosis?
por: Kim, Tae Wan, et al.
Publicado: (2012)